Delivery Order SPE2DB20D1100-SPE2DB23FC5T7

Award Date 7/14/23
Potential Completion Date 7/17/23
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $1,006.57 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 500 pioglitazone hydrochloride 30 mg tablets. The delivery order was issued under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with all supplies to be delivered between September 6-7,...
The Defense Logistics Agency awarded a $127,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90,000 pioglitazone hydrochloride 15 mg tablets. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver the ordered medications from its facility in Conshohocken, Pennsylvania to an unspecified customer within the DLA supply chain network. The delivery order was issued on July 18, 2023 under an existing DLA...
The Defense Logistics Agency Troop Support Medical awarded a $86,640 delivery order to Amerisourcebergen Drug Corporation for 30,000 pioglitazone hydrochloride 30 mg tablets. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by July 28, 2023. No subcontractors or set aside designations were identified....
The Defense Logistics Agency awarded a $1,714.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561709549 Pioglitazone HCl 15 mg tablets, 90 count. The delivery order was issued against an existing Prime Vendor contract vehicle to provide pharmaceutical products and services to DLA and DoD customers. Performance will take place at Amerisourcebergen's distribution facility in Conshohocken, Pennsylvania, with all supplies to be delivered by August 7, 2023....
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $177,000 firm fixed price delivery order to supply 30-count bottles of 15mg pioglitazone HCl tablets. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania distribution center. The order period of performance is September 21-22, 2023. As a major supplier of pharmaceuticals to the Department of Defense through contracts like the DLA's Pharmaceutical Prime Vendor program, Amerisourcebergen will deliver...
The Defense Logistics Agency awarded a $1,241.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 tablets of pioglitazone hydrochloride 45 mg. The contract has a period of performance from June 27, 2023 through June 28, 2023. Amerisourcebergen Drug Corporation will fulfill the order from its facility located in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals to the Department of Defense, this small order for diabetes medication supports the Defense...
The Defense Logistics Agency awarded a $648 delivery order to Amerisourcebergen Drug Corporation for pioglitazone hydrochloride 30 mg tablets. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 30-count bottles of the diabetes medication to a facility in Conshohocken, Pennsylvania between September 11-12, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for pioglitazone tablets supports the Defense...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred twenty-one dollars and forty-two cents to Amerisourcebergen Drug Corporation for pioglitazone hydrochloride 45 mg tablets. Under the contract, Amerisourcebergen will deliver 30 tablets to a facility in Conshohocken, Pennsylvania, with performance required from July 17 through July 18, 2023. As a major supplier of pharmaceuticals and medical supplies to the U.S. Department of Defense, this order for...
The Defense Logistics Agency awarded a $151,380 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562252833 pioglitazone hydrochloride 45 mg tablets. Under this contract, Amerisourcebergen will deliver 30 tablets of the specified medication to an address in Conshohocken, Pennsylvania by September 21, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense and its military services, suggesting this...
<p>The Defense Logistics Agency awarded a $32,490 delivery order to Amerisourcebergen Drug Corporation for 30-count bottles of 30mg pioglitazone HCl tablets. To be performed in Conshohocken, Pennsylvania under firm fixed price terms from August 16-17, 2023. No additional details were provided regarding the solicitation, vehicle, or subcontractors. The single-award delivery order supports the Defense Logistics Agency's medical supply needs.</p>
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB23FC5T7
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,554 to Amerisourcebergen Drug Corporation for the supply of 500 pioglitazone hydrochloride 30 mg tablets. The order was placed under an existing prime vendor contract vehicle to support the DLA's pharmaceutical procurement programs. Performance will occur at Amerisourcebergen's distribution facility in Conshohocken, Pennsylvania over a three-day period concluding on July 17, 2023. No subcontractors or set aside designations were identified. The order continues the DLA's practice of leveraging pre-competed contracts to efficiently fulfill critical medical material needs for the U.S. military and other defense agencies.

Generated 12/24/23, 6:24 PM